A Michigan Medicine-led study found that patients in the United States with a rare form of scleroderma have a greater chance of dying from related kidney, heart, and lung problems, despite taking medications used to treat most patients with the disease. The research team assessed more than 300 patients diagnosed with, or at risk for,...